News | January 10, 2025
Carbogen Amcis successfully completed Swissmedic inspection of its Vionnaz facility
The site’s GMP Certification has been successfully renewed
The site’s GMP Certification has been successfully renewed
The EIR was issued with an inspection classification of Voluntary Action Indicated (VAI) post the inspection of the facility from September 16 to September 27, 2024
The inspection, which is a routine part of the FDA's regulatory oversight, evaluates compliance with Good Manufacturing Practices and other regulatory requirements.
NutrifyGenie AI, a leading AI-driven platform, was integral in designing scientifically differentiated formulations for a multinational client
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Zefylti will be available as 30 MU/0.5 mL and 48 MU/0.5 mL and is intended for the treatment of neutropenia and the mobilisation of peripheral progenitor cells
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
Subscribe To Our Newsletter & Stay Updated
